Avidity Biosciences, Inc.
Avidity Biosciences, Inc. (RNA) Stock Overview
Explore Avidity Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
11.3B
P/E Ratio
-18.27
EPS (TTM)
$-4.19
ROE
-0.38%
RNA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Avidity Biosciences, Inc. (RNA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 61.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $75.35.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -18.27 and a market capitalization of 11.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.